IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q3 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the IDEXX Laboratories Third Quarter 2023 Earnings Conference Call. As a reminder, today's conference is being recorded.
Stay updated with breaking news from Cyte One. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Good morning, and welcome to the IDEXX Laboratories Third Quarter 2023 Earnings Conference Call. As a reminder, today's conference is being recorded.
Dublin, Oct. 31, 2023 (GLOBE NEWSWIRE) -- The "Global Veterinary Hematology Analyzers Market 2023" report has been added to ResearchAndMarkets.com's offering. The global veterinary hematology analyzers market is set to experience robust growth, with a projected increase from $0.83 billion in 2022 to $0.90 billion in 2023, indicating a compound annual growth rate (CAGR) of 8.7%. The market is anticipated to reach $1.21 billion in 2027, demonstrating a CAGR of 7.6%. Zoonotic Disease Prevalence Dri
Operator: Good morning, and welcome to the IDEXX Laboratories Second Quarter 2023 Earnings Conference Call. As a reminder, today's conference is being recorded.
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q2 2023 Earnings Call Transcript August 1, 2023 IDEXX Laboratories, Inc. misses on earnings expectations. Reported EPS is $1.56 EPS, expectations were $2.47. Operator: Good morning, and welcome to the IDEXX Laboratories Second Quarter 2023 Earnings Conference Call. As a reminder, today’s conference is being recorded. Participating in the call this […]
IDEXX benefits from strong secular growth and its ability to turn high growth into rapidly rising free cash flow used to buy back stock. Read more about IDXX.